München Klinik gGmbH

Munich 81975

2 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Non-Small Cell Lung Cancer

Studies at this site

• Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects — Recruiting now
• Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients — Recruiting now